Ferring announces recipients of 2018-19 Innovation Grants
-Ferring Pharmaceuticals today announced the recipients of the 2018-19 Ferring Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego.
Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer
-Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer…
Ferring Pharmaceuticals and Evotec AG form strategic research alliance in reproductive medicine and women’s health
-Ferring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced a strategic research alliance…
Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health
-Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian…
New analysis of Rekovelle® data further supports use of AMH to personalise fertility treatment
-Ferring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial…
Archives Press release 2018
Archives Press release 2018